Continuous glucose monitoring may improve glycaemic control

CGM monitor

This systematic review of randomised trials found nine studies that investigated whether continuous glucose monitoring (CGM) compared with self-monitoring of blood glucose (SMBG) led to improved glycaemic control or a reduction in hypoglycaemic episodes. The reviewers combined the results of the study in a meta-analysis to measure the benefit of CGM compared with conventional treatment [read the full story…]

Share this post: Share on Facebook Tweet this on Twitter Share on LinkedIn Share on Google+ Share via email

No difference between insulin detemir and glargine in control of type 2 diabetes

Picture of a syringe

This systematic review identified four studies that directly compared insulin detemir with glargine.  The reviewers found no clinically significant difference between detemir and glargine in terms of glyaemic control (HbA1c), nor in rates of hypoglycaemia. Insulin detemir was associated with less weight gain, but glargine patients used less insulin and had fewer adverse reactions to [read the full story…]